Consent to the Distribution of New Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines which were referred to the Minister of Health under the provisions of section 24(5) of the Act and are set out in the Schedule hereto:

Schedule

*Product:*	Evrysdi
Active Ingredient:	Risdiplam 0.75mg/mL
Dosage Form:	Powder for oral solution
New Zealand Sponsor:	Roche Products (NZ) Limited
Manufacturer:	F Hoffmann-La Roche Limited, Basel, Switzerland

*Product:*	Pimafucort
Active Ingredients:	Hydrocortisone 1% Natamycin 1% Neomycin sulfate 0.35%
Dosage Form:	Topical ointment
New Zealand Sponsor:	LEO Pharma Limited
Manufacturers:	Astellas Pharma Europe B.V., Meppel, Netherlands Temmler Italia S.r.l., Carugate, Italy

Dated this 29th day of March 2023.

CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).

Tags

Notice Number

Schedule